aTyr Pharma (ATYR) Revenue & Revenue Breakdown


OverviewForecastFinancialsChartTranscripts

aTyr Pharma Revenue Highlights


Latest Revenue (Y)

$190.00K

Latest Revenue (Q)

$190.00K

Main Segment (Y)

Collaboration Revenue

aTyr Pharma Revenue by Period


aTyr Pharma Revenue by Year

DateRevenueChange
2025-12-31$190.00K-19.15%
2024-12-31$235.00K-33.43%
2023-12-31$353.00K-96.60%
2022-12-31$10.39M100.00%
2021-12-31--100.00%
2020-12-31$10.46M2377.49%
2019-12-31$422.00K100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--

aTyr Pharma generated $190.00K in revenue during NA 2025, up -19.15% compared to the previous quarter, and up 1.82% compared to the same period a year ago.

aTyr Pharma Revenue by Quarter

DateRevenueChange
2025-09-30$190.00K100.00%
2025-06-30-100.00%
2025-03-31-100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30--100.00%
2024-03-31$235.00K100.00%
2023-12-31--100.00%
2023-09-30$353.00K100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$10.39M100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$2.05M1287.16%
2020-09-30$148.00K-21.69%
2020-06-30$189.00K-97.66%
2020-03-31$8.06M5500.69%
2019-12-31$144.00K-21.74%
2019-09-30$184.00K95.74%
2019-06-30$94.00K100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31--

aTyr Pharma generated $190.00K in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

aTyr Pharma Revenue Breakdown


aTyr Pharma Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25
Collaboration Revenue$200.00K

aTyr Pharma's latest annual revenue breakdown by segment (product or service), as of Dec 25: Collaboration Revenue (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25
Collaboration Revenue-$200.00K

aTyr Pharma Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
DTILPrecision BioSciences$34.26M$13.00K
MGXMetagenomi$25.21M$8.66M
HYFTMindWalk$24.52M$6.98M
ATYRaTyr Pharma$190.00K$190.00K
ALXOALX Oncology--
RPTXRepare Therapeutics--
QNCXQuince Therapeutics--
RLMDRelmada Therapeutics--
UNCYUnicycive Therapeutics--
ACRVAcrivon Therapeutics--
CAMPCAMP4 Therapeutics-$795.00K

ATYR Revenue FAQ


What is aTyr Pharma’s yearly revenue?

aTyr Pharma's yearly revenue for 2025 was $190K, representing a decrease of -19.15% compared to 2024. The company's yearly revenue for 2024 was $235K, representing a decrease of -33.43% compared to 2023. ATYR's yearly revenue for 2023 was $353K, representing a decrease of -96.60% compared to 2022.

What is aTyr Pharma’s quarterly revenue?

aTyr Pharma's quarterly revenue for Q3 2025 was $190K, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). ATYR's quarterly revenue for Q1 2025 was $0, a 100.00% increase from the previous quarter (Q4 2024), and a -100.00% decrease year-over-year (Q1 2024).

What is aTyr Pharma’s revenue growth rate?

aTyr Pharma's revenue growth rate for the last 3 years (2023-2025) was -46.18%, and for the last 5 years (2021-2025) was 0%.

What are aTyr Pharma’s revenue streams?

aTyr Pharma's revenue streams in c 25 are Collaboration Revenue

What is aTyr Pharma’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of aTyr Pharma was Collaboration Revenue. This segment made a revenue of $200K, representing 100.00% of the company's total revenue.